Finance

Lists
Why is L020 up 2,22%?
Dive Deeper
L020:FRA
Britannia Life Sciences Inc
€0,023
+2,22%
(+0,00050) 1D
2 Okt., 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for L020...
Open
€0,02
High
€0,02
Low
€0,02
Mkt. cap
10,52 m
Volume
0,00
52-wk high
€0,07
52-wk low
€0,02
No. of employees
28
Open
€0,02
High
€0,02
Low
€0,02
Mkt. cap
10,52 m
Volume
0,00
52-wk high
€0,07
52-wk low
€0,02
No. of employees
28
News stories
From web sources and news partners
About Britannia Life Sciences Inc
CEO-
Employees28
Founded2000
Headquarters-
SectorService
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
111,87 k
65,36 k
127,84 k
101,37 k
Cost of goods sold
73,34 k
29,44 k
128,93 k
81,94 k
Cost of revenue
73,34 k
29,44 k
128,93 k
81,94 k
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
720,52 k
399,98 k
177,00
362,03 k
Operating expense
736,35 k
415,70 k
15,85 k
377,78 k
Total operating expenses
809,68 k
445,14 k
144,77 k
459,72 k
Operating income
-697,82 k
-379,78 k
-16,94 k
-358,35 k
Other non operating income
-
-
-66,34 k
-
EBT including unusual items
-411,28 k
12,51 m
2,17 m
1,20 m
EBT excluding unusual items
-526,26 k
-155,36 k
428,09 k
148,35 k
Income tax expense
-
1,67 m
-1,17 m
-
Effective tax rate
-
13,38%
-53,69%
-
Other operating expenses
-
-
-
-
Net income
-411,28 k
12,13 m
3,63 m
1,20 m
Net profit margin
-367,65%
18 555,35%
2 835,86%
1 182,14%
Earnings per share
-
-
-
-
Interest and investment income
99,32 k
311,64 k
308,22 k
355,00 k
Interest expense
-6,68 k
-5,76 k
-4,92 k
-4,30 k
Net interest expenses
92,63 k
305,88 k
303,30 k
350,70 k
Depreciation and amortization charges
15,83 k
15,72 k
15,67 k
15,76 k
EBITDA
-681,99 k
-364,06 k
-1,27 k
-342,59 k
Gain or loss from assets sale
-58,73 k
-
-
-
AI content may include mistakes. Learn more
Google-programme